Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02260323

Enrollment

300

Registered

2014-10-09

Start date

2014-10-31

Completion date

2022-02-28

Last updated

2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Rheumatic Diseases

Brief summary

To evaluate the compliance of traditional Chinese medicine (TCM) in young people with Chronic rheumatic disease

Interventions

OTHERpatient-tailored anti-arthritis herbs

patient use tailored anti-arthritis herbs

OTHERpatient-tailored DMARDs

patient use tailored disease-modifying antirheumatic drugs

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 35 Years

Healthy volunteers

Inclusion criteria

* were between 18 and 35 years of age * without use of TCM in the previous 3 months * and had a Steinbrocker functional status of class I, II, or III

Exclusion criteria

* previous general health conditions disallowed their use of TCM * were pregnant * lack of motivation, remote from home, time-consuming,intervention, or other personal difficulties

Design outcomes

Primary

Measure	Time frame
Changes from baseline in HBCS(Hill-Bone Compliance Scale) score at 48 weeks	at 0 week, 12 weeks, 24 weeks, 48 weeks
Changes from baseline in MARS(Medication Adherence Rating Scale) score at 48 weeks	at 0 week, 12 weeks, 24 weeks, 48 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026